European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Past deals in DACH

Marvel Fusion

Series B in 2025
Marvel Fusion is a Munich-based company established in 2019 that specializes in the development of fusion energy technology. The company focuses on creating a laser-based nuclear fusion reactor designed to provide environmentally friendly and safe energy solutions. Its innovative reactor utilizes short pulse, high energy, and electrically efficient lasers, making it suitable for the commercialization of baseload fusion electrical power. By advancing this technology, Marvel Fusion aims to enable consumers to access clean, reliable energy sources, contributing to a sustainable energy future.

Onward

Grant in 2024
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Axelera AI

Series B in 2024
Axelera AI is a company focused on advancing artificial intelligence through its specialized hardware and software platforms, particularly for edge computing applications. Its flagship product, the Metis™ AI Platform, combines innovative hardware and software to offer high-performance and energy-efficient AI inference solutions. Recognized for its innovation, the platform was honored at the CES® 2024 Innovation Awards. Established in 2021, Axelera AI was incubated by Bitfury, a leader in emerging technologies, and partnered with imec, a prominent nano-technology group. The company is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices located in Belgium, Switzerland, and Italy. The team consists of experts in AI software and hardware, many of whom have backgrounds with leading AI firms and Fortune 500 companies. Axelera AI’s platform features a unique custom dataflow architecture with multicore in-memory computing, enabling clients to achieve optimal power efficiency while supporting various networks for sustainable edge applications.

FarmInsect

Series A in 2023
FarmInsect GmbH, established in 2019 and headquartered in Bergkirchen, Germany, specializes in automated insect breeding systems. The company develops machines and IoT solutions that enable regional farmers to rear insects on-site for use as animal feed, primarily for chickens, pigs, and fish. This sustainable approach aims to replace imported soy or fishmeal with locally produced protein feed, thereby enhancing the efficiency of animal husbandry while reducing environmental impact.

Nanogence

Venture Round in 2023
Nanogence SA is a Swiss company established in 2017, specializing in the development of innovative material solutions for the construction sector. Based in Renens, the company focuses on creating synthetic, tailor-made materials utilizing advanced nanotechnology and chemistry. Its patented additive formulations enhance the performance of cement and concrete, significantly improving their binding efficiency while also aiming to reduce carbon emissions by up to 50%. By providing environmentally friendly chemicals and additives, Nanogence enables manufacturers in the construction industry to lower costs, enhance durability, and contribute to sustainable practices. The company operates within a rapidly growing global construction market, which underscores the importance of its contributions to more efficient and eco-friendly building materials.

Swisspod Technologies

Grant in 2023
Swisspod Technologies SA is a transportation development firm based in Monthey, Switzerland, founded in 2019. The company specializes in designing and developing energy-efficient Hyperloop systems, which are innovative tube-based transportation solutions aimed at providing high-speed travel between distant cities. Swisspod's Hyperloop pods are fully electric and designed to be sustainable and affordable, emphasizing environmental responsibility and economic viability. The firm is committed to advancing high-speed transportation through cutting-edge Swiss engineering and is assembling a team of multidisciplinary experts dedicated to revolutionizing the future of travel.

Xeltis

Series D in 2023
Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

ONO

Convertible Note in 2023
Creating transformative change in urban mobility, making our cities cleaner and more enjoyable. We first focus on urban logistics, moving goods around the city in ways that are sustainable, efficient and cost-effective. Our vehicle and its modular platform system, with easily swappable modular units, meets the needs of city logistics. From moving food to flowers to furniture, the possibilities are endless. ONO’s founders, pioneer in e-mobility solutions, Beres Seelbach, former head of design at Mercedes and Volkswagen, Murat Günak, and light electric vehicle expert and engineer, Philipp Kahle, sought to rethink and reshape modern urban transportation. They put together a forward-thinking group of designers, engineers and creative thinkers who shared their vision of transforming urban mobility. ONO is a Berlin-based e-mobility company introducing a whole new category of emissions-free vehicle: the Pedal Assisted Transporter (PAT), combining the flexibility of a bicycle with the capacity and durability of a van. We offer environmentally friendly urban logistics solutions designed and optimised for cities of today.

EBAMed

Series A in 2023
EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.

TreaTech

Series A in 2023
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.

Naco

Grant in 2023
Naco Technologies Ltd is a manufacturer and supplier of advanced nano-coating technologies, specializing in high-performance coatings for various industries including tooling, automotive, aerospace, and microchip production. Founded in 2009 and headquartered in Riga, Latvia, Naco develops multilayer and multicomponent coatings that enhance equipment performance by providing oil-enhanced, wear-protective, thermal barrier, and liquid-repellent properties. The company plays a significant role in the hydrogen sector by creating specialized coatings for Green Hydrogen systems, such as electrolyzers and fuel cells, which improve the reliability of these systems while minimizing the use of costly and scarce materials. In 2015, Naco Technologies was acquired by the Schaeffler Group, a Germany-based company, further strengthening its capabilities and market reach.

nyris

Venture Round in 2023
nyris GmbH is a Berlin-based company that specializes in developing a visual search platform designed to enhance product discovery by allowing users to search for items using images and videos. Established in 2015, nyris employs advanced technologies such as artificial intelligence and neural networks to deliver search results in under one second. This innovative platform serves a diverse clientele across various sectors, including retail and e-commerce, industrial and manufacturing, media and entertainment, and financial services. By facilitating a more intuitive search experience, nyris helps organizations improve efficiency and reduce friction associated with traditional text-based search methods. The company operates additional locations in Dusseldorf and has established a global presence, serving customers in over 50 countries.

Wingtra

Series B in 2023
Wingtra AG is a Swiss company specializing in the manufacturing of vertical take-off and landing (VTOL) drones, particularly the WingtraOne model. Founded in 2014 and headquartered in Zürich, WingtraOne is designed for high-precision aerial data collection, serving various industries such as surveying, agriculture, forestry, and infrastructure. Since its introduction to the market in 2017, the drone has gained recognition for its capability to facilitate the digitization of environments, particularly for surveying professionals in sectors including construction, mining, environmental monitoring, and urban planning. Wingtra has established partnerships with over 50 leading surveying equipment dealers worldwide, enhancing its presence in the global market. The drone operates with WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into detailed two-dimensional maps and three-dimensional models, thereby providing valuable insights for monitoring and inspection activities across multiple industries.

iThera Medical

Venture Round in 2022
iThera Medical is a biotechnology company founded in 2010 as a spin-off from the Helmholtz Zentrum Muenchen, specializing in photonic molecular imaging technology. The company focuses on the development of its proprietary multispectral optoacoustic tomography (MSOT) technology, which offers real-time visualization of anatomical, functional, and molecular information in living tissues. This innovative imaging solution enhances the ability of healthcare professionals to detect tumors and inflammatory diseases non-invasively, thereby facilitating preclinical and clinical trials. By advancing its technology, iThera Medical aims to improve diagnostic capabilities and patient outcomes in the medical field.

Resistell

Series B in 2022
Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

Precisis

Grant in 2022
Precisis is a medical device company founded in 2004 and headquartered in Heidelberg, Baden-Württemberg, Germany. The company focuses on developing innovative products aimed at treating epilepsy and enhancing patients' quality of life. Its flagship device provides individualized brain stimulation through a surgical procedure that places the device beneath the scalp, precisely targeting the origin of epileptic activity in the brain. This technology allows for the delivery of therapeutic currents to specific areas, enabling effective treatment without direct contact with brain tissue.

IonKraft

Grant in 2022
IonKraft, a German technology company, specializes in plasma coating for multi-material plastic containers. Their innovative plasma-enhanced chemical vapor deposition process enables recyclability of complex packaging, serving industries such as food, pharmaceuticals, cosmetics, and chemicals. By promoting material reduction and reuse, IonKraft aims to enhance performance while lowering costs, with support from the German Federal Ministry for Economic Affairs and Energy.

Nano4Imaging

Grant in 2022
Nano4Imaging GmbH, established in 2011 and located in Aachen, Germany, specializes in the development and production of contrast agents and devices designed for in-vivo imaging of medical implants and minimally invasive devices. The company offers a range of products, including MRWire EmeryGlide, a magnetic resonance imaging (MRI) conditional guidewire, and various coatings under the MagnaFy brand that enhance the visibility of devices in different imaging modalities, such as MRI, computed tomography (CT), and X-ray. These innovations facilitate navigation and monitoring during medical interventions, particularly in the treatment of cardiovascular diseases and in radiotherapy. By leveraging advanced nanotechnology, Nano4Imaging aims to improve the accuracy of patient monitoring and intervention outcomes.

ABCDx

Venture Round in 2022
ABCDx SA is a privately-funded company based in Geneva, Switzerland, founded in 2014 by three experts in the field of brain biomarkers. The founders include two prominent researchers from the Faculty of Medicine at the University of Geneva and the Vall d’Hebron Research Institute, who are recognized for their contributions to biomarker discovery and validation. The third founder brings extensive experience in the diagnostic and pharmaceutical industries. ABCDx specializes in the development and validation of biomarker and biomarker panel tests aimed at enhancing the diagnosis and treatment of brain injuries. The company's offerings are designed to identify and assess patients at risk of severe long-term complications stemming from traumatic injuries, strokes, and post-stroke infections. Through its innovative approach, ABCDx aims to improve patient outcomes in the realm of brain health.

Scantrust

Grant in 2022
ScanTrust SA is a company specializing in a cloud-based IoT platform that enhances supply chain visibility and product authentication. Founded in 2014 and headquartered in Lausanne, Switzerland, with operations in Shanghai, Singapore, and Bangkok, ScanTrust employs secure unique identifiers to connect products and packaging to the Internet. Its offerings include a printer portal for packaging and label partners to integrate secure codes into existing processes, an online portal for real-time business intelligence and supply chain insights, and secure QR codes that can be verified by smartphones. This technology enables brand owners to protect their products from counterfeiting while providing detailed supply chain control and opportunities for consumer engagement.

ONO

Series A in 2022
Creating transformative change in urban mobility, making our cities cleaner and more enjoyable. We first focus on urban logistics, moving goods around the city in ways that are sustainable, efficient and cost-effective. Our vehicle and its modular platform system, with easily swappable modular units, meets the needs of city logistics. From moving food to flowers to furniture, the possibilities are endless. ONO’s founders, pioneer in e-mobility solutions, Beres Seelbach, former head of design at Mercedes and Volkswagen, Murat Günak, and light electric vehicle expert and engineer, Philipp Kahle, sought to rethink and reshape modern urban transportation. They put together a forward-thinking group of designers, engineers and creative thinkers who shared their vision of transforming urban mobility. ONO is a Berlin-based e-mobility company introducing a whole new category of emissions-free vehicle: the Pedal Assisted Transporter (PAT), combining the flexibility of a bicycle with the capacity and durability of a van. We offer environmentally friendly urban logistics solutions designed and optimised for cities of today.

Positrigo

Series B in 2022
Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.

Celeris Therapeutics

Venture Round in 2022
Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

IRUBIS

Convertible Note in 2022
IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.

IRUBIS

Seed Round in 2022
IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.

Vatorex

Convertible Note in 2022
Vatorex AG is a Swiss company based in Winterthur that specializes in developing electronic solutions to combat varroa mites, a significant threat to honey bee populations. Founded in 2016, the company offers innovative products designed for hive management and monitoring. Its flagship Varroa Solution employs a hyperthermic treatment system that utilizes controlled heat to eliminate varroa mites without harming the bees. Additionally, Vatorex provides the Full Hive Kit, which includes real-time monitoring and data collection capabilities, and the Hive Manager, a mobile application for organizing hive-related information. By focusing on effective and practical treatments, Vatorex aims to enhance honey bee health and support the beekeeping industry.

ABCDx

Grant in 2022
ABCDx SA is a privately-funded company based in Geneva, Switzerland, founded in 2014 by three experts in the field of brain biomarkers. The founders include two prominent researchers from the Faculty of Medicine at the University of Geneva and the Vall d’Hebron Research Institute, who are recognized for their contributions to biomarker discovery and validation. The third founder brings extensive experience in the diagnostic and pharmaceutical industries. ABCDx specializes in the development and validation of biomarker and biomarker panel tests aimed at enhancing the diagnosis and treatment of brain injuries. The company's offerings are designed to identify and assess patients at risk of severe long-term complications stemming from traumatic injuries, strokes, and post-stroke infections. Through its innovative approach, ABCDx aims to improve patient outcomes in the realm of brain health.

tozero

Pre Seed Round in 2022
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, specializes in lithium-ion battery recycling technology. The company aims to accelerate decarbonization efforts by developing a scalable and sustainable machine for recovering critical materials such as lithium, nickel, cobalt, graphite, and manganese from various battery types. By enabling industries to reintroduce these valuable raw materials into the supply chain, Tozero contributes to more sustainable practices in battery production and reduces dependency on virgin resources.

Onward

Grant in 2022
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Reactive Robotics

Grant in 2022
ReActive Robotics GmbH, established in April 2015 and based in Gilching, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's rehabilitation robots are specifically utilized for gait rehabilitation in neurological patients as well as in orthopedic patients recovering from joint replacements. With a team boasting over 12 years of combined experience in rehabilitation robotics and a strong network within the clinical community, ReActive Robotics is well-equipped to advance its innovative solutions in medical technology. The company emphasizes the importance of collaboration with advisors who support various aspects of product development, including patient access, engineering, legal compliance, and medical device registration.

Vanevo

Grant in 2022
Vanevo GmbH, established in 2018 and located in Oldenburg, Germany, specializes in the development and production of components for redox flow batteries. The company focuses on creating stacks and modules designed to enhance the affordability and accessibility of electricity storage. Vanevo's innovative approach enables the storage of electrical energy in two tanks, allowing for efficient charging and discharging within the battery stacks. By offering economically durable solutions, Vanevo aims to provide users with cost-effective options for energy storage, addressing the growing demand for reliable and sustainable energy solutions.

FarmInsect

Grant in 2022
FarmInsect GmbH, established in 2019 and headquartered in Bergkirchen, Germany, specializes in automated insect breeding systems. The company develops machines and IoT solutions that enable regional farmers to rear insects on-site for use as animal feed, primarily for chickens, pigs, and fish. This sustainable approach aims to replace imported soy or fishmeal with locally produced protein feed, thereby enhancing the efficiency of animal husbandry while reducing environmental impact.

Celeris Therapeutics

Grant in 2022
Celeris Therapeutics is an AI-first drug discovery company that focuses on developing proximity-inducing compounds (PICs), particularly PIC degraders, to address high unmet medical needs in diseases like Parkinson's and various cancers. The company has created the Celeris One platform, which utilizes structure-based geometric deep learning to enhance the design and development of degraders by prioritizing specific E3 ligases, designing effective linkers, and selecting optimal compounds for synthesis. Additionally, Celeris Therapeutics operates an in-house automated laboratory that facilitates rapid generation of experimental data for further optimization. The company collaborates with pharmaceutical and biotech firms to discover and develop small-molecule degrader therapies across multiple therapeutic areas, while also advancing its own internal drug pipeline. Celeris Therapeutics maintains offices in Menlo Park, California, and Graz, Austria.

Tripleye

Grant in 2022
Tripleye is a Berlin-based company founded in 2020 that specializes in providing a technology platform for the development of autonomous vehicles. The company offers automation solutions that supply engineering teams with essential technology modules. Its platform utilizes industry-standard cameras to enhance safety and deliver high-precision measurements across a full 360-degree range. This capability enables clients to support diverse applications, including autonomous machines and human-robot interactions.

Tripleye

Venture Round in 2022
Tripleye is a Berlin-based company founded in 2020 that specializes in providing a technology platform for the development of autonomous vehicles. The company offers automation solutions that supply engineering teams with essential technology modules. Its platform utilizes industry-standard cameras to enhance safety and deliver high-precision measurements across a full 360-degree range. This capability enables clients to support diverse applications, including autonomous machines and human-robot interactions.

SiPearl

Grant in 2022
SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

SiPearl

Series A in 2022
SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

Plair SA

Grant in 2022
Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

OxyPrem

Grant in 2022
OxyPrem AG is a Swiss company that specializes in the development, design, and manufacturing of advanced sensor solutions specifically for monitoring preterm infants. Established in 2018 and headquartered in Zurich, the company offers a reusable device that continuously measures hemoglobin oxygen saturation in the brains of high-risk preterm infants. By utilizing harmless near-infrared light technology, OxyPrem provides real-time monitoring, which significantly enhances the clinical care provided to this vulnerable patient group. The innovations from OxyPrem aim to prevent early death and severe long-term brain damage, thereby minimizing the risk of disabilities and other complications associated with premature birth.

Dimpora

Grant in 2022
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly functional membranes for the outdoor textile industry. The company produces waterproof, fluorine-free membranes primarily made from polyurethane, utilizing a template removal approach to create porosity that enhances breathability. Dimpora's innovative technology allows for the direct application of membranes onto various surfaces, facilitating fast moisture transport while ensuring complete rain protection. Committed to sustainability, Dimpora aims to develop high-performance membranes that enable outdoor enthusiasts to enjoy nature responsibly, with a focus on creating next-generation solutions that may incorporate recyclable materials.

Artiria Medical

Grant in 2022
Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

embotech

Grant in 2022
embotech AG, founded in 2013 and based in Zurich, Switzerland, specializes in developing software solutions for autonomous systems that focus on numerical optimization. Their flagship product, FORCES Pro, allows for the effective design of complex control systems by solving intricate optimization problems rapidly. The software has diverse applications, including the control of wind turbines, collision-free motion planning for autonomous drones, the enhancement of advanced driver assistance systems, and enabling precise landings for spacecraft on other planets, as well as the retrieval of reusable rockets. Embotech caters to various sectors, including automotive, energy, and robotics, positioning itself as a leader in creating advanced decision-making technologies essential for future autonomous systems.

Oxara

Grant in 2022
Oxara AG, founded in 2018 and based in Zurich, Switzerland, specializes in developing sustainable building products aimed at addressing challenges in the construction industry, such as resource scarcity and high CO2 emissions from cement production. The company offers a range of innovative materials, including additives and its flagship poured earth concrete, which is produced using locally available landfill waste. This eco-friendly alternative to traditional concrete retains the benefits of conventional materials while being significantly cheaper and reducing environmental impact by up to 90%. Oxara's mission extends beyond product development; it aims to foster a global community committed to sustainable construction and affordable housing, while prioritizing the well-being of its employees and clients.

Crocus Labs

Grant in 2022
Crocus Labs GmbH is a Berlin-based deep tech company specializing in advanced light engine technology aimed at creating a more sustainable future. The company focuses on developing intelligent light-emitting diode (LED) solutions that reduce energy costs and enhance growth conditions for indoor farms. By employing advanced data analytics, Crocus Labs offers precise lighting control that optimizes plant growth while minimizing energy consumption. Their innovative approach supports vertical farming and greenhouse operations, allowing for the efficient cultivation of a diverse range of crops without sacrificing electrical efficiency. The company's expertise in energy-saving lighting applications serves residential, commercial, and industrial sectors globally.

Crocus Labs

Venture Round in 2022
Crocus Labs GmbH is a Berlin-based deep tech company specializing in advanced light engine technology aimed at creating a more sustainable future. The company focuses on developing intelligent light-emitting diode (LED) solutions that reduce energy costs and enhance growth conditions for indoor farms. By employing advanced data analytics, Crocus Labs offers precise lighting control that optimizes plant growth while minimizing energy consumption. Their innovative approach supports vertical farming and greenhouse operations, allowing for the efficient cultivation of a diverse range of crops without sacrificing electrical efficiency. The company's expertise in energy-saving lighting applications serves residential, commercial, and industrial sectors globally.

Dermagnostix

Grant in 2022
Dermagnostix is a German company founded in 2020, located in the Freiburg and Munich areas. It specializes in developing innovative dermatology diagnostics aimed at enhancing clinical practice and improving patient experiences. The company offers a molecular diagnostic platform that facilitates rapid and objective diagnostics for skin diseases, particularly in distinguishing between eczema and psoriasis at a molecular level. This technology empowers healthcare professionals to provide better care and treatment options, ultimately improving the lives of patients with dermatological conditions.

Computomics

Grant in 2022
Computomics GmbH is a bioinformatics company based in Tübingen, Germany, specializing in molecular data analysis for crop biotechnology and agricultural research. Founded in 2012, the company employs advanced artificial intelligence and machine learning techniques to provide a range of services, including genome assembly, transcriptome studies, and genomic selection. Computomics focuses on analyzing complex plant genomes, offering solutions such as differential gene expression analysis, reference-free genotyping, and DNA methylation analysis. Its interactive visualization tools empower researchers to make data-driven decisions while ensuring thorough analysis and comprehensive reporting of genomic data. With a diverse team of experts in machine learning, biology, and bioinformatics, Computomics has successfully completed over 190 projects, facilitating sustainable agricultural development and aiding in the advancement of global food security.

Nagi Bioscience

Grant in 2022
Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

Qnami

Grant in 2022
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Bloom Biorenewables

Grant in 2022
Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.

Headmade Materials

Grant in 2022
Headmade Materials GmbH is a German company based in Würzburg, focused on developing materials and processes for metal 3D printing, specifically utilizing the ColdMetalFusion technique. Founded in 2019, the company specializes in creating binder-based materials for the additive manufacturing of serial parts. Headmade Materials offers a range of services, including part design for 3D printing, production of standard and customized feedstocks, and process consulting. Their expertise extends to application support for additive-compatible designs and reliable production processes, enabling clients to achieve cost-effective manufacturing of advanced printed metal components. Additionally, the company provides small-scale series production and implementation support directly at customer sites, simplifying the post-processing of components and enhancing overall output.

Headmade Materials

Series A in 2022
Headmade Materials GmbH is a German company based in Würzburg, focused on developing materials and processes for metal 3D printing, specifically utilizing the ColdMetalFusion technique. Founded in 2019, the company specializes in creating binder-based materials for the additive manufacturing of serial parts. Headmade Materials offers a range of services, including part design for 3D printing, production of standard and customized feedstocks, and process consulting. Their expertise extends to application support for additive-compatible designs and reliable production processes, enabling clients to achieve cost-effective manufacturing of advanced printed metal components. Additionally, the company provides small-scale series production and implementation support directly at customer sites, simplifying the post-processing of components and enhancing overall output.

DyeMansion

Venture Round in 2022
DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

Smartlane

Grant in 2022
Smartlane GmbH, founded in 2015 and based in Munich, Germany, specializes in developing innovative software solutions for transportation logistics. The company's flagship product, SmartlaneDISPATCH!, is a mobile application that facilitates order and tour management, enabling users to monitor deliveries, optimize routes, and communicate with customers via notifications. Additionally, Smartlane offers Smartlane Transport Intelligence, a cloud-based, AI-driven platform that automates and optimizes transport planning. This technology enhances operational efficiency by dispatching orders quickly while taking into account various factors such as delivery time windows and real-time traffic data. Smartlane's solutions are particularly beneficial for delivery services, field service providers, and businesses with vehicle fleets, significantly reducing operational costs and environmental impact. As a leader in the sector, Smartlane is dedicated to digitizing and improving transportation processes for its clients.

Bioweg

Venture Round in 2022
Bioweg, established in Germany in 2019, is a purpose-driven company specializing in the development and sale of advanced sustainable and bio-based ingredients for B2B applications. By integrating biotechnology, material science, and molecular simulation learning, Bioweg produces high-performance ingredients that are 100% animal-free, sustainably manufactured using green chemistry, and globally scalable. The company collaborates with innovative brands in sectors such as cosmetics, personal care, agricultural technology, and food and beverage, aiming to address business challenges with tailored solutions. Utilizing a zero-waste circular process, Bioweg repurposes food industry waste as feedstock to create bio-based microbeads, rheology modifiers, and hydrocolloids that are free of microplastics and compliant with emerging regulations.

Xeltis

Grant in 2021
Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Xeltis

Venture Round in 2021
Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels using a proprietary polymer-based technology. Xeltis' RestoreX platform enables the body's natural healing system to develop tissue that replaces the implant, forming a new functional valve or vessel. The company's restorative devices include implantable small diameter blood vessels for hemodialysis and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. Xeltis has raised funding from various venture capital firms and European institutions, including a €30 million round in 2021.

Bioweg

Grant in 2021
Bioweg, established in Germany in 2019, is a purpose-driven company specializing in the development and sale of advanced sustainable and bio-based ingredients for B2B applications. By integrating biotechnology, material science, and molecular simulation learning, Bioweg produces high-performance ingredients that are 100% animal-free, sustainably manufactured using green chemistry, and globally scalable. The company collaborates with innovative brands in sectors such as cosmetics, personal care, agricultural technology, and food and beverage, aiming to address business challenges with tailored solutions. Utilizing a zero-waste circular process, Bioweg repurposes food industry waste as feedstock to create bio-based microbeads, rheology modifiers, and hydrocolloids that are free of microplastics and compliant with emerging regulations.

SwissDeCode

Grant in 2021
SwissDeCode is a Swiss company based in Renens that specializes in food safety and compliance services for food manufacturers. Founded in 2016, it offers rapid onsite DNA testing solutions that allow production facilities to confirm food authenticity, safety, and origin. By providing plug-and-play systems, SwissDeCode enables factories to obtain food safety and quality certifications within the same work shift, facilitating immediate decision-making for inspectors. This approach not only addresses contamination threats but also transforms them into sustainable opportunities for food producers.

iThera Medical

Grant in 2021
iThera Medical is a biotechnology company founded in 2010 as a spin-off from the Helmholtz Zentrum Muenchen, specializing in photonic molecular imaging technology. The company focuses on the development of its proprietary multispectral optoacoustic tomography (MSOT) technology, which offers real-time visualization of anatomical, functional, and molecular information in living tissues. This innovative imaging solution enhances the ability of healthcare professionals to detect tumors and inflammatory diseases non-invasively, thereby facilitating preclinical and clinical trials. By advancing its technology, iThera Medical aims to improve diagnostic capabilities and patient outcomes in the medical field.

iThera Medical

Venture Round in 2021
iThera Medical is a biotechnology company founded in 2010 as a spin-off from the Helmholtz Zentrum Muenchen, specializing in photonic molecular imaging technology. The company focuses on the development of its proprietary multispectral optoacoustic tomography (MSOT) technology, which offers real-time visualization of anatomical, functional, and molecular information in living tissues. This innovative imaging solution enhances the ability of healthcare professionals to detect tumors and inflammatory diseases non-invasively, thereby facilitating preclinical and clinical trials. By advancing its technology, iThera Medical aims to improve diagnostic capabilities and patient outcomes in the medical field.

Computomics

Venture Round in 2021
Computomics GmbH is a bioinformatics company based in Tübingen, Germany, specializing in molecular data analysis for crop biotechnology and agricultural research. Founded in 2012, the company employs advanced artificial intelligence and machine learning techniques to provide a range of services, including genome assembly, transcriptome studies, and genomic selection. Computomics focuses on analyzing complex plant genomes, offering solutions such as differential gene expression analysis, reference-free genotyping, and DNA methylation analysis. Its interactive visualization tools empower researchers to make data-driven decisions while ensuring thorough analysis and comprehensive reporting of genomic data. With a diverse team of experts in machine learning, biology, and bioinformatics, Computomics has successfully completed over 190 projects, facilitating sustainable agricultural development and aiding in the advancement of global food security.

PYDRO

Venture Round in 2021
Pydro GmbH, founded in 2016 and headquartered in Hamburg, Germany, develops innovative solutions for water management. The company specializes in modular water turbines designed for smart pressure management and energy recovery within water pipe networks. Its flagship products include the PT1 and PT2 Pydro Turbines, which convert energy surpluses from water flow into usable power. These turbines are tailored for various applications, such as running monitoring equipment and operating pressure management devices, chlorination systems, remote terminals, and sump pumps. Pydro's technology aims to enhance the efficiency of water utilities by providing eco-friendly monitoring and sensing solutions that utilize energy derived from water flow, facilitating precise flow measurement and streamlining device-to-cloud communication for cost-effective deployment across large-scale water systems.

SiPearl

Venture Round in 2021
SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

PYDRO

Grant in 2021
Pydro GmbH, founded in 2016 and headquartered in Hamburg, Germany, develops innovative solutions for water management. The company specializes in modular water turbines designed for smart pressure management and energy recovery within water pipe networks. Its flagship products include the PT1 and PT2 Pydro Turbines, which convert energy surpluses from water flow into usable power. These turbines are tailored for various applications, such as running monitoring equipment and operating pressure management devices, chlorination systems, remote terminals, and sump pumps. Pydro's technology aims to enhance the efficiency of water utilities by providing eco-friendly monitoring and sensing solutions that utilize energy derived from water flow, facilitating precise flow measurement and streamlining device-to-cloud communication for cost-effective deployment across large-scale water systems.

MagnoTherm

Grant in 2021
MagnoTherm, founded in 2019 and headquartered in Darmstadt, Germany, specializes in innovative magnetic cooling and heating technologies. With a team of over 40 experts in magnetocaloric materials, the company is committed to addressing the climate crisis by revolutionizing the cooling industry, which accounts for approximately 7% of global CO2 emissions. MagnoTherm's technology offers an alternative to traditional gas compression systems, boasting up to 30% greater energy efficiency while being non-explosive, non-flammable, and requiring low maintenance. The company aims to meet the increasing demand for sustainable and cost-effective cooling solutions, providing a viable pathway for policymakers to transition from outdated gas compression methods that have remained unchanged for nearly two centuries.

SiPearl

Grant in 2021
SiPearl is a French semiconductor company established in 2019 and headquartered in Maisons-Laffitte, Île-de-France. The company specializes in designing high-performance, low-power microprocessors aimed at powering exascale supercomputers. Its flagship product, Rhea, is based on the Arm Neoverse V1 architecture and is set to be commercialized in early 2024. SiPearl's microprocessors are intended for a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, catering to scientific researchers as well as prominent players in the IT, electronics, and automotive industries. The company is committed to producing its microprocessors using advanced manufacturing processes from TSMC, specifically N6 or better. SiPearl also maintains research and development centers across France, Germany, and Spain, aligning its roadmap with the European Union's technological goals.

FarmInsect

Seed Round in 2021
FarmInsect GmbH, established in 2019 and headquartered in Bergkirchen, Germany, specializes in automated insect breeding systems. The company develops machines and IoT solutions that enable regional farmers to rear insects on-site for use as animal feed, primarily for chickens, pigs, and fish. This sustainable approach aims to replace imported soy or fishmeal with locally produced protein feed, thereby enhancing the efficiency of animal husbandry while reducing environmental impact.

Positrigo

Series A in 2021
Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.

GrOwnValve

Grant in 2021
GrOwnValve is a Berlin-based medical device company founded in 2019, focused on addressing the clinical need for personalized heart valve prostheses. The company is developing an innovative heart valve prosthesis system that enables minimally invasive replacement procedures using the patient's own tissue. This approach aims to provide a safe, affordable, and effective solution for patients suffering from heart valve defects, enhancing their treatment options and overall outcomes. GrOwnValve’s commitment to leveraging advanced medical technology positions it at the forefront of cardiac care innovation.

nyris

Grant in 2021
nyris GmbH is a Berlin-based company that specializes in developing a visual search platform designed to enhance product discovery by allowing users to search for items using images and videos. Established in 2015, nyris employs advanced technologies such as artificial intelligence and neural networks to deliver search results in under one second. This innovative platform serves a diverse clientele across various sectors, including retail and e-commerce, industrial and manufacturing, media and entertainment, and financial services. By facilitating a more intuitive search experience, nyris helps organizations improve efficiency and reduce friction associated with traditional text-based search methods. The company operates additional locations in Dusseldorf and has established a global presence, serving customers in over 50 countries.

GrOwnValve

Venture Round in 2021
GrOwnValve is a Berlin-based medical device company founded in 2019, focused on addressing the clinical need for personalized heart valve prostheses. The company is developing an innovative heart valve prosthesis system that enables minimally invasive replacement procedures using the patient's own tissue. This approach aims to provide a safe, affordable, and effective solution for patients suffering from heart valve defects, enhancing their treatment options and overall outcomes. GrOwnValve’s commitment to leveraging advanced medical technology positions it at the forefront of cardiac care innovation.

ADVITOS

Venture Round in 2021
ADVITOS GmbH is a Munich-based company that specializes in the design, development, and marketing of extracorporeal multiple organ support therapy products for hospitals in Germany. Founded in 2004, the company offers an innovative treatment method known as ADVanced organ support, which utilizes albumin dialysis to facilitate the removal of various toxins from the liver, lungs, and kidneys. This method enables the elimination of CO2, hepatic toxins, and both water-soluble and protein-bound nephrotoxins, while also addressing metabolic and respiratory acidosis. The ADVOS system operates using standard dialysis accesses and flow rates, distinguishing itself by not requiring gas exchangers for CO2 removal.

Reactive Robotics

Venture Round in 2021
ReActive Robotics GmbH, established in April 2015 and based in Gilching, Germany, specializes in the design, manufacture, and sale of rehabilitation robots aimed at facilitating early movement rehabilitation following neurological injuries and orthopedic surgeries. The company's rehabilitation robots are specifically utilized for gait rehabilitation in neurological patients as well as in orthopedic patients recovering from joint replacements. With a team boasting over 12 years of combined experience in rehabilitation robotics and a strong network within the clinical community, ReActive Robotics is well-equipped to advance its innovative solutions in medical technology. The company emphasizes the importance of collaboration with advisors who support various aspects of product development, including patient access, engineering, legal compliance, and medical device registration.

AgroSustain

Grant in 2021
AgroSustain SA is a Swiss company founded in 2018 that specializes in developing innovative solutions for biological plant protection. Based in Nyon, the company focuses on detecting and preventing the development of harmful molds on important crops during the post-harvest phase. AgroSustain utilizes natural plant extracts to combat fungal pathogens such as botrytis cinerea and fusarium oxysporum, offering organic treatments that extend the shelf life of fruits and vegetables. By promoting sustainable practices, AgroSustain aims to reduce food waste and plastic consumption through its farm-to-fork solutions, which include biological fungicides and protective coatings. The company's commitment to sustainability and organic food production aligns with the growing demand for environmentally friendly agricultural practices.

UniSieve

Venture Round in 2020
UniSieve Ltd is a cleantech company based in Zurich, Switzerland, specializing in the development and manufacturing of mechanically flexible molecular sieving membranes. Founded in 2018, UniSieve utilizes a unique platform technology that combines various molecular sieves with polymeric membranes to create reliable separation solutions. These membranes are designed for a diverse array of applications, including chemical feedstock purification, biogas upgrading, gas and liquid separation, sensing, and space-related uses. By providing advanced molecular separation systems, UniSieve aims to enhance energy efficiency, reduce carbon dioxide emissions, and improve recycling rates for its clients, ultimately contributing to operational cost savings.

Wingtra

Grant in 2020
Wingtra AG is a Swiss company specializing in the manufacturing of vertical take-off and landing (VTOL) drones, particularly the WingtraOne model. Founded in 2014 and headquartered in Zürich, WingtraOne is designed for high-precision aerial data collection, serving various industries such as surveying, agriculture, forestry, and infrastructure. Since its introduction to the market in 2017, the drone has gained recognition for its capability to facilitate the digitization of environments, particularly for surveying professionals in sectors including construction, mining, environmental monitoring, and urban planning. Wingtra has established partnerships with over 50 leading surveying equipment dealers worldwide, enhancing its presence in the global market. The drone operates with WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into detailed two-dimensional maps and three-dimensional models, thereby providing valuable insights for monitoring and inspection activities across multiple industries.

Wingtra

Venture Round in 2020
Wingtra AG is a Swiss company specializing in the manufacturing of vertical take-off and landing (VTOL) drones, particularly the WingtraOne model. Founded in 2014 and headquartered in Zürich, WingtraOne is designed for high-precision aerial data collection, serving various industries such as surveying, agriculture, forestry, and infrastructure. Since its introduction to the market in 2017, the drone has gained recognition for its capability to facilitate the digitization of environments, particularly for surveying professionals in sectors including construction, mining, environmental monitoring, and urban planning. Wingtra has established partnerships with over 50 leading surveying equipment dealers worldwide, enhancing its presence in the global market. The drone operates with WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into detailed two-dimensional maps and three-dimensional models, thereby providing valuable insights for monitoring and inspection activities across multiple industries.

ONO

Series A in 2020
Creating transformative change in urban mobility, making our cities cleaner and more enjoyable. We first focus on urban logistics, moving goods around the city in ways that are sustainable, efficient and cost-effective. Our vehicle and its modular platform system, with easily swappable modular units, meets the needs of city logistics. From moving food to flowers to furniture, the possibilities are endless. ONO’s founders, pioneer in e-mobility solutions, Beres Seelbach, former head of design at Mercedes and Volkswagen, Murat Günak, and light electric vehicle expert and engineer, Philipp Kahle, sought to rethink and reshape modern urban transportation. They put together a forward-thinking group of designers, engineers and creative thinkers who shared their vision of transforming urban mobility. ONO is a Berlin-based e-mobility company introducing a whole new category of emissions-free vehicle: the Pedal Assisted Transporter (PAT), combining the flexibility of a bicycle with the capacity and durability of a van. We offer environmentally friendly urban logistics solutions designed and optimised for cities of today.

Vatorex

Grant in 2020
Vatorex AG is a Swiss company based in Winterthur that specializes in developing electronic solutions to combat varroa mites, a significant threat to honey bee populations. Founded in 2016, the company offers innovative products designed for hive management and monitoring. Its flagship Varroa Solution employs a hyperthermic treatment system that utilizes controlled heat to eliminate varroa mites without harming the bees. Additionally, Vatorex provides the Full Hive Kit, which includes real-time monitoring and data collection capabilities, and the Hive Manager, a mobile application for organizing hive-related information. By focusing on effective and practical treatments, Vatorex aims to enhance honey bee health and support the beekeeping industry.

Electrochaea

Venture Round in 2020
Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

SwissDeCode

Grant in 2020
SwissDeCode is a Swiss company based in Renens that specializes in food safety and compliance services for food manufacturers. Founded in 2016, it offers rapid onsite DNA testing solutions that allow production facilities to confirm food authenticity, safety, and origin. By providing plug-and-play systems, SwissDeCode enables factories to obtain food safety and quality certifications within the same work shift, facilitating immediate decision-making for inspectors. This approach not only addresses contamination threats but also transforms them into sustainable opportunities for food producers.

Positrigo

Grant in 2020
Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.

Positrigo

Series A in 2020
Positrigo AG is a Zurich-based company specializing in the development, manufacturing, and sales of dedicated brain positron emission tomography (PET) scanners. Founded in 2018, Positrigo focuses on providing functional imaging solutions that facilitate the early detection of neurodegenerative diseases, particularly Alzheimer's disease, as well as other conditions like Lewy body dementia, vascular dementia, and frontotemporal dementia. The company's PET scanners are designed to be accessible and affordable, enabling healthcare professionals to diagnose and monitor treatment effectively, while also contributing to the advancement of new therapies in the field of neurology.

Resistell

Grant in 2020
Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

ONO

Grant in 2020
Creating transformative change in urban mobility, making our cities cleaner and more enjoyable. We first focus on urban logistics, moving goods around the city in ways that are sustainable, efficient and cost-effective. Our vehicle and its modular platform system, with easily swappable modular units, meets the needs of city logistics. From moving food to flowers to furniture, the possibilities are endless. ONO’s founders, pioneer in e-mobility solutions, Beres Seelbach, former head of design at Mercedes and Volkswagen, Murat Günak, and light electric vehicle expert and engineer, Philipp Kahle, sought to rethink and reshape modern urban transportation. They put together a forward-thinking group of designers, engineers and creative thinkers who shared their vision of transforming urban mobility. ONO is a Berlin-based e-mobility company introducing a whole new category of emissions-free vehicle: the Pedal Assisted Transporter (PAT), combining the flexibility of a bicycle with the capacity and durability of a van. We offer environmentally friendly urban logistics solutions designed and optimised for cities of today.

DyeMansion

Grant in 2020
DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

Electrochaea

Grant in 2020
Electrochaea GmbH is a German company specializing in the development and commercialization of innovative power-to-gas energy storage technology. Founded in 2010 and headquartered in Planegg, Germany, with additional facilities in Denmark and California, Electrochaea's proprietary biocatalytic process converts low-cost electricity and carbon dioxide into pipeline-grade renewable methane, the primary component of natural gas. This technology enables the efficient storage of renewable energy generated from sources like wind and solar, facilitating grid balancing and carbon recycling. By converting stranded electricity into renewable gas, Electrochaea provides a solution for utility-scale energy storage and supports the decarbonization of transportation and natural gas grids. The company aims to enhance existing infrastructure for energy transmission and contribute to a more sustainable energy landscape.

TreaTech

Grant in 2020
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.

Nanogence

Venture Round in 2020
Nanogence SA is a Swiss company established in 2017, specializing in the development of innovative material solutions for the construction sector. Based in Renens, the company focuses on creating synthetic, tailor-made materials utilizing advanced nanotechnology and chemistry. Its patented additive formulations enhance the performance of cement and concrete, significantly improving their binding efficiency while also aiming to reduce carbon emissions by up to 50%. By providing environmentally friendly chemicals and additives, Nanogence enables manufacturers in the construction industry to lower costs, enhance durability, and contribute to sustainable practices. The company operates within a rapidly growing global construction market, which underscores the importance of its contributions to more efficient and eco-friendly building materials.

TreaTech

Venture Round in 2020
TreaTech is a Swiss cleantech company established in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company specializes in developing catalytic hydrothermal gasification (cHTG) technology that offers an innovative approach to wastewater treatment. This thermochemical process effectively transforms various types of liquid waste, including sewage sludge, into valuable by-products such as renewable gas, clean water, and mineral salts. TreaTech's solutions focus on eco-friendly waste disposal, aligning with sustainable development and circular economy principles. By recycling wastewater and its by-products, TreaTech enables clients to manage waste more sustainably while generating resources like fertilizers and biogas.

Vatorex

Venture Round in 2020
Vatorex AG is a Swiss company based in Winterthur that specializes in developing electronic solutions to combat varroa mites, a significant threat to honey bee populations. Founded in 2016, the company offers innovative products designed for hive management and monitoring. Its flagship Varroa Solution employs a hyperthermic treatment system that utilizes controlled heat to eliminate varroa mites without harming the bees. Additionally, Vatorex provides the Full Hive Kit, which includes real-time monitoring and data collection capabilities, and the Hive Manager, a mobile application for organizing hive-related information. By focusing on effective and practical treatments, Vatorex aims to enhance honey bee health and support the beekeeping industry.

Nanogence

Grant in 2020
Nanogence SA is a Swiss company established in 2017, specializing in the development of innovative material solutions for the construction sector. Based in Renens, the company focuses on creating synthetic, tailor-made materials utilizing advanced nanotechnology and chemistry. Its patented additive formulations enhance the performance of cement and concrete, significantly improving their binding efficiency while also aiming to reduce carbon emissions by up to 50%. By providing environmentally friendly chemicals and additives, Nanogence enables manufacturers in the construction industry to lower costs, enhance durability, and contribute to sustainable practices. The company operates within a rapidly growing global construction market, which underscores the importance of its contributions to more efficient and eco-friendly building materials.

ADVITOS

Grant in 2020
ADVITOS GmbH is a Munich-based company that specializes in the design, development, and marketing of extracorporeal multiple organ support therapy products for hospitals in Germany. Founded in 2004, the company offers an innovative treatment method known as ADVanced organ support, which utilizes albumin dialysis to facilitate the removal of various toxins from the liver, lungs, and kidneys. This method enables the elimination of CO2, hepatic toxins, and both water-soluble and protein-bound nephrotoxins, while also addressing metabolic and respiratory acidosis. The ADVOS system operates using standard dialysis accesses and flow rates, distinguishing itself by not requiring gas exchangers for CO2 removal.

Mindpeak

Grant in 2020
MindPeak GmbH is a technology company based in Hamburg, Germany, founded in 2018. It specializes in developing artificial intelligence software tools aimed at enhancing the accuracy and efficiency of cancer diagnostics. The company's flagship product, BreastAI, is designed for the quantification of breast cancer immunohistochemistry (IHC) and can be integrated into third-party software systems. MindPeak's solutions automate tissue diagnostics, enabling pathologists to identify and quantify tumorous regions and detect breast cancer cells more effectively. By streamlining tasks such as cell and biomarker quantification, MindPeak's tools allow cancer specialists to focus on critical decision-making in clinical environments, ultimately improving patient care while making diagnostic processes more accessible and cost-effective.

SwissDeCode

Venture Round in 2020
SwissDeCode is a Swiss company based in Renens that specializes in food safety and compliance services for food manufacturers. Founded in 2016, it offers rapid onsite DNA testing solutions that allow production facilities to confirm food authenticity, safety, and origin. By providing plug-and-play systems, SwissDeCode enables factories to obtain food safety and quality certifications within the same work shift, facilitating immediate decision-making for inspectors. This approach not only addresses contamination threats but also transforms them into sustainable opportunities for food producers.

Seervision

Grant in 2020
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

IRUBIS

Venture Round in 2020
IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.

EBAMed

Grant in 2020
EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.

IRUBIS

Grant in 2020
IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.